Skip to main content
. 2017 Jun 15;7(6):e014218. doi: 10.1136/bmjopen-2016-014218

Table 4.

Hazard ratios for hypokalaemia in patients treated with YK preparations*

Risk factors Univariable analysis Multivariable analysis
Hazard ratio (95% CI) p Value Hazard ratio (95% CI) p Value
YK administration (not YKCH) 2.84 (1.37 to 5.87) 0.005 3.09 (1.41 to 6.80) 0.005
LPIDs co-administration 2.88 (1.89 to 4.38) <0.001 2.74 (1.75 to 4.29) <0.001
Hypoalbuminaemia† 2.95 (1.94 to 4.49) <0.001 2.15 (1.36 to 3.38) 0.001
Fully-dosed amount 1.64 (1.05 to 2.55) 0.029 1.60 (1.01 to 2.55) 0.048
Female 1.36 (0.89 to 2.06) 0.153 1.32 (0.85 to 2.03) 0.215
Age 1.00 (0.99 to 1.02) 0.537 1.00 (0.99 to 1.02) 0.673
Serum potassium† (≥4.1 mEq/L) 0.36 (0.24 to 0.54) <0.001 0.45 (0.29 to 0.70) <0.001

*Cox proportional hazard model was used.

†Determined at baseline.

LPIDs, lower potassium-inducing drugs; YK, Yokukansan; YKCH, Yokukansan-ka-chimpihange.